{
  "meta": {
    "title": "Anxiety_Disorders",
    "url": "https://brainandscalpel.vercel.app/anxiety-disorders-323d58e8.html",
    "scrapedAt": "2025-11-30T11:20:14.820Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Fear is a response to an unknown threat, while anxiety to a known threat</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Fear is a response to an external object, while anxiety to an internal object/feeling</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Fear is an alerting signal to vague threats, while anxiety is to definite threats</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Only anxiety activates the sympathetic system, while fear does not</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Anxiety can be differentiated from fear response by which of the following characteristics?</span></p>",
      "unique_key": "DT1154574",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154574,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Fear is a response to a known, definite, external threat, typically with a clear source and serving as an alerting signal.</p>\n<p>Anxiety, on the other hand, arises from an internal, vague, and conflictual source without a definite external object, serving as an alarming signal.</p>\n<ul>\n<li><strong>Definitions &amp; Features:</strong>\n<ul>\n<li><strong>Fear</strong>: Emotional reaction to external, definite danger. <strong>(Option A, C ruled out)</strong></li>\n<li><strong>Anxiety</strong>: Emotional reaction to an internal, indefinite threat. (<strong>Option A, C ruled out)</strong></li>\n<li>Fear is <strong>non-conflictual</strong>, while anxiety often emerges from <strong>internal conflict</strong>.</li>\n<li>Both activate the autonomic nervous system, but anxiety is usually more persistent and diffuse. <strong>(Option D ruled out)</strong><br /> </li>\n</ul>\n</li>\n<li><strong>Pathophysiology:</strong>\n<ul>\n<li>Fear: Mediated by the amygdala and an immediate sympathetic response.</li>\n<li>Anxiety: Modulated by corticolimbic circuits and neurotransmitters (serotonin, norepinephrine, GABA).</li>\n</ul>\n</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715B4C.png\">\n<ul>\n<li><strong>Management:</strong>\n<ul>\n<li>Fear: Direct response to external danger, usually resolves with threat removal.</li>\n<li>Anxiety: Managed with psychotherapy (CBT, supportive), pharmacotherapy (SSRIs, benzodiazepines).</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Flumazenil</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenobarbitone</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Prazosin</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Fomepizole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which medication among these is a recognised panicogen?</span></p>",
      "unique_key": "DT1154576",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154576,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Flumazenil, a <strong>GABA-b receptor inverse agonist</strong>, is a well-known panicogen that can provoke panic attacks in individuals with panic disorder.</p>\n<p><strong>Panicogens:</strong></p>\n<ul>\n<li>Panicogens are substances that induce panic attacks by disrupting neurochemical or respiratory balance.</li>\n<li><strong>Types of Panicogens:</strong>\n<ul>\n<li><strong>Respiratory Panicogens</strong> (alter blood gases and pH):\n<ul>\n<li>Carbon dioxide (5&ndash;35% mixtures)</li>\n<li>Sodium lactate</li>\n<li>Sodium bicarbonate</li>\n</ul>\n</li>\n<li><strong>Neurochemical Panicogens</strong> (affect neurotransmitters):\n<ul>\n<li><strong>Flumazenil</strong> (inverse agonist at benzodiazepine receptors on GABA-b complex)</li>\n<li>Yohimbine (alpha-2 adrenergic antagonist)</li>\n<li>mCPP and m-carboline derivatives (serotonin system modulators)</li>\n<li>Cholecystokinin (CCK)</li>\n<li>Caffeine (adenosine receptor antagonist)</li>\n<li>Isoproterenol (beta-adrenergic agonist, though the mechanism is not fully understood)</li>\n</ul>\n</li>\n<li><strong>Mechanism of Flumazenil:</strong>\n<ul>\n<li>Acts as an inverse agonist at <strong>benzodiazepine recognition sites</strong> on the GABA receptor, causing <strong>anxiogenic effects</strong> in susceptible individuals.</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Phenobarbitone (Option B):</strong> A barbiturate sedative, it <strong>reduces CNS activity</strong> and does not act as a panicogen.</p>\n<p><strong>Prazosin (Option C): </strong>An alpha-1 adrenergic blocker, used in <strong>PTSD-related nightmares</strong>, not a panicogen.</p>\n<p><strong>Fomepizole (Option D): </strong>Used to treat <strong>methanol/ethylene glycol poisoning</strong>, with no panicogenic effects.</p>",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Specific phobia</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Social anxiety</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Post traumatic stress disorder</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">All the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Panic attacks are associated with which of the following conditions?</span></p>",
      "unique_key": "DT1154585",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154585,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Panic attacks are intense, discrete episodes of fear or discomfort that peak within minutes, and they are not restricted to panic disorder alone.</li>\n<li>They are frequently associated with <strong>specific phobia, social anxiety disorder, and post-traumatic stress disorder (PTSD),</strong> and can occur as part of several other psychiatric conditions.</li>\n<li><strong>Disorders Commonly Associated with Panic Attacks:</strong>\n<ul>\n<li><strong>Specific Phobia</strong>: Exposure to the phobic stimulus can trigger panic attacks. <strong>(Option A)</strong></li>\n<li><strong>Social Anxiety Disorder (Social Phobia)</strong>: Panic attacks often occur in performance or social situations. <strong>(Option B)</strong></li>\n<li><strong>Post Traumatic Stress Disorder (PTSD)</strong>: Panic attacks are common in response to trauma reminders. <strong>(Option C)</strong></li>\n<li><strong>Obsessive-Compulsive Disorder (OCD)</strong>: Severe anxiety with panic attacks during intrusive thoughts or compulsions.</li>\n<li><strong>Depression</strong>: Panic attacks may be comorbid, especially with severe anxiety.</li>\n<li><strong>Personality Disorders</strong>: Cluster C personality traits (e.g., avoidant, dependent) may predispose to panic attacks.</li>\n<li><strong>Substance Use Disorders</strong>: Withdrawal states or intoxication can provoke panic attacks.<br /> </li>\n</ul>\n</li>\n<li><strong>Clinical Features of a Panic Attack:</strong>\n<ul>\n<li>Sudden onset of intense fear or discomfort.</li>\n<li>Peak within 10 minutes, with symptoms like palpitations, sweating, trembling, shortness of breath, and fear of dying or losing control.</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Apprehensive anxiety about additional panic attacks</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Phobic avoidance, i.e., avoiding the place/situation in which a panic attack occurs</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Fear of impending doom</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A and B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following criteria should be present along with panic attacks to make a diagnosis of panic disorder according to DSM-5?</span></p>",
      "unique_key": "DT1154587",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154587,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>According to <strong>DSM-5 criteria</strong>, for a diagnosis of <strong>Panic Disorder</strong>, there must be recurrent, unexpected panic attacks.</li>\n<li>In addition, at least <strong>one month (or more)</strong> of one or both of the following:\n<ul>\n<li>Persistent concern or worry about having more panic attacks or their consequences (e.g., fear of going crazy, heart attack).</li>\n<li>A significant <strong>maladaptive behavioural change</strong> related to the attacks (e.g., avoidance of activities or places that may trigger attacks).</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>DSM-5 Diagnostic Criteria for Panic Disorder:</strong>\n<ul>\n<li>Recurrent unexpected panic attacks.</li>\n<li>At least one attack is followed by <strong>1 month (or more)</strong> of:\n<ul>\n<li><strong>Persistent apprehensive anxiety</strong> about additional attacks. <strong>(Option A)</strong></li>\n<li><strong>Maladaptive behavioural changes</strong> (phobic avoidance). <strong>(Option B)</strong></li>\n</ul>\n</li>\n<li>Not attributable to the physiological effects of a substance/medical condition.</li>\n<li>Not better explained by another mental disorder (e.g., phobia, PTSD, OCD).</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Fear of impending doom (Option C): </strong>This is a symptom of the panic attack, not a DSM-5 criterion for panic disorder diagnosis.</p>",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperthyroidism</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Pheochromocytoma</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Anemia</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following medical disorders mimics a panic attack?</span></p>",
      "unique_key": "DT1154597",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154597,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Several medical conditions can produce <strong>symptoms similar to panic attacks</strong>, including palpitations, sweating, tremors, and a sense of impending doom.</li>\n<li><strong>Hyperthyroidism (Option A)</strong>, <strong>pheochromocytoma (Option B)</strong>, and <strong>anaemia (Option C)</strong> are classic examples of conditions that can cause such symptoms and should be considered in the differential diagnosis.</li>\n<li><strong>Key Organic Causes That Can Mimic Panic Disorder:</strong></li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715D5E.png\">",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Fear that escape might be difficult in specific situations</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Fear that panic-like symptoms or embarrassing symptoms may occur in specific situations</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">No clinically significant distress is present despite the symptoms</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A) And B)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is/are true for Agoraphobia?</span></p>",
      "unique_key": "DT1154609",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154609,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In agoraphobia, individuals fear or avoid specific situations because of thoughts that <strong>escape might be difficult</strong> or that <strong>help might not be available</strong> if panic-like symptoms or other incapacitating or embarrassing symptoms develop.</li>\n<li>According to <strong>DSM-5 </strong>, these two fears <strong>(Option A and B)</strong> are central to the diagnosis of agoraphobia.</li>\n<li><strong>Diagnostic Features:</strong>\n<ul>\n<li>Individuals typically avoid situations like using public transportation, being in open spaces, standing in line, being in a crowd, or being outside the home alone.</li>\n<li>The core concern is that <strong>escape may be difficult</strong> or <strong>help unavailable</strong> if panic-like symptoms or other distressing symptoms occur (e.g., fear of falling in the elderly, fear of incontinence).</li>\n<li>This avoidance causes significant distress or impairment in social, occupational, or other important areas of functioning. <strong>(Option C ruled out)</strong></li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Specific phobia</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Panic disorder</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Generalised anxiety disorder</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Substance use disorders</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The 'Little Albert experiment' by John Watson, shown in the diagram below, is a model to explain which disorder?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715F6G.png\"></span></p>",
      "unique_key": "DT1154614",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154614,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The \"Little Albert experiment\" demonstrates <strong>classical conditioning</strong> in the development of a <strong>specific phobia</strong>.</p>\n<ul>\n<li>In this experiment, a child (Albert) learned to fear a previously neutral stimulus (white rat) after it was paired repeatedly with a loud noise.</li>\n<li><strong>Definition:</strong>\n<ul>\n<li><strong>Specific Phobia</strong>: Marked fear or anxiety about a specific object or situation that is actively avoided or endured with intense fear.</li>\n</ul>\n</li>\n<li><strong>Etiology:</strong>\n<ul>\n<li>The <strong>behavioural model</strong> explains phobia development through <strong>classical conditioning</strong>:\n<ul>\n<li>A neutral stimulus (e.g., white rat) becomes associated with an aversive unconditioned stimulus (e.g., loud noise).</li>\n<li>This leads to a <strong>conditioned fear response</strong> to the previously neutral object.</li>\n</ul>\n</li>\n<li><strong>Pathophysiology:</strong>\n<ul>\n<li>Involves hyperactivity of the <strong>amygdala</strong> and limbic circuits responsible for fear responses.</li>\n<li>Conditioning strengthens synaptic pathways in fear circuits.</li>\n</ul>\n</li>\n<li><strong>Clinical Features:</strong>\n<ul>\n<li>Persistent, excessive fear triggered by specific objects or situations (e.g., animals, heights, flying).</li>\n<li>Exposure leads to immediate anxiety responses.</li>\n<li>Individuals <strong>actively avoid</strong> or endure with significant distress.</li>\n</ul>\n</li>\n<li><strong>Investigations:</strong>\n<ul>\n<li>Clinical diagnosis through <strong>history and mental status examination</strong>.</li>\n<li>No specific laboratory or imaging tests are required.</li>\n</ul>\n</li>\n<li><strong>Management:</strong>\n<ul>\n<li><strong>Behaviour therapy</strong>: Exposure therapy, systematic desensitisation.</li>\n<li><strong>Cognitive-behavioural therapy (CBT)</strong>: Restructuring fear-based thoughts.</li>\n<li>Pharmacotherapy: SSRIs or benzodiazepines (for severe, impairing phobias only).</li>\n</ul>\n</li>\n<li><strong>Flowchart: Development of Specific Phobia (Little Albert Model):</strong></li>\n</ul>\n</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715H7J.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Panic disorder (Option B): </strong>Characterised by recurrent panic attacks, not a learned fear of a specific stimulus.</p>\n<p><strong>Generalised anxiety disorder (Option C):</strong> Chronic, generalised worry; not typically conditioned to a single object.</p>\n<p><strong>Substance use disorders (Option D):</strong> No direct link to conditioned learning of specific fear.</p>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Nosophobia</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Tomophobia</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Nosocomephobia</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Mysophobia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old man with no significant medical history reports extreme distress whenever he must accompany his elderly grandmother to the hospital. He becomes anxious even at the thought of entering the hospital and often avoids accompanying her, despite knowing she requires his help. He reports that his fear is specifically of hospitals, not of getting ill himself. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1154617",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154617,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Nosocomephobia</strong> is the term for an intense, irrational fear of hospitals, leading to <strong>avoidance behaviours</strong> and significant distress.</p>\n<ul>\n<li>In this clinical scenario, the patient&rsquo;s fear is not of infection, surgery, or germs in general-it is specifically of hospitals as a place.</li>\n<li><strong>Definition:</strong>\n<ul>\n<li><strong>Nosocomephobia</strong>: Specific phobia characterised by <strong>persistent, excessive fear</strong> of hospitals.</li>\n</ul>\n</li>\n<li><strong>Etiology:</strong>\n<ul>\n<li>May arise from <strong>traumatic experiences in hospitals</strong> (e.g., personal or family experiences with illness, death, or surgery).</li>\n<li><strong>Classical conditioning</strong> and <strong>observational learning</strong> also play roles (e.g., observing distress in family members during hospital visits).</li>\n</ul>\n</li>\n<li><strong>Pathophysiology:</strong>\n<ul>\n<li>Involves hyperactivity of the <strong>amygdala</strong> and fear circuits.</li>\n<li>Reinforced by <strong>avoidance behaviours</strong>, the phobia is maintained.</li>\n</ul>\n</li>\n<li><strong>Clinical Features:</strong>\n<ul>\n<li><strong>An immediate anxiety response</strong> when exposed to the hospital setting.</li>\n<li>Recognised as <strong>excessive and unreasonable</strong> by the individual.</li>\n<li>Leads to <strong>avoidance</strong> or significant distress/impairment in daily activities.</li>\n</ul>\n</li>\n<li><strong>Investigations:</strong>\n<ul>\n<li>Primarily <strong>clinical diagnosis</strong> based on <strong>history and mental status examination</strong>.</li>\n<li>No laboratory tests required.</li>\n</ul>\n</li>\n<li><strong>Management:</strong>\n<ul>\n<li><strong>Cognitive Behavioural Therapy (CBT)</strong>:\n<ul>\n<li>Systematic desensitisation and exposure therapy to reduce conditioned fear.</li>\n<li>Cognitive restructuring to modify catastrophic thoughts about hospitals.</li>\n</ul>\n</li>\n<li><strong>Pharmacotherapy</strong> (adjunctive):\n<ul>\n<li><strong>SSRIs</strong> for severe cases.</li>\n<li><strong>Short-term benzodiazepines</strong> for acute anxiety in unavoidable hospital visits.</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Nosophobia (Option A):</strong> Fear of <strong>developing an illness</strong>, not of the hospital.</p>\n<p><strong>Tomophobia (Option B): </strong>Fear of <strong>surgery or medical procedures</strong>.</p>\n<p><strong>Mysophobia (Option D):</strong> Fear of <strong>germs and contamination</strong>, not the hospital.</p>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 correct</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3 correct</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3 correct</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3 correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true for the blood-injection-injury type of specific phobia?<br> 1.\tOne of the most common types of specific phobia<br> 2.\tBradycardia and hypotension are characteristically seen compared to tachycardia, which is seen in other phobias<br> 3.\tHas a high familial tendency</span></p>",
      "unique_key": "DT1154618",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154618,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>All three statements are correct</strong> for <strong>blood-injection-injury phobia</strong>. This phobia is common, characterised by a biphasic autonomic response (<strong>bradycardia and hypotension</strong>) and has a strong familial pattern.</p>\n<ul>\n<li><strong>Definition:</strong>\n<ul>\n<li>A type of <strong>specific phobia</strong> with intense fear of blood, injections, or injury-related stimuli.</li>\n</ul>\n</li>\n<li><strong>Etiology:</strong>\n<ul>\n<li>Genetic predisposition and <strong>classical conditioning</strong> (traumatic experiences or observational learning).</li>\n<li>High familial aggregation suggests a genetic basis.</li>\n</ul>\n</li>\n<li><strong>Pathophysiology:</strong>\n<ul>\n<li>Involves a <strong>biphasic autonomic response</strong>:\n<ul>\n<li><strong>Initial sympathetic surge</strong> (tachycardia).</li>\n<li>Followed by <strong>parasympathetic overactivity</strong> (vagal stimulation) &rarr; <strong>bradycardia and hypotension</strong>, leading to fainting.</li>\n</ul>\n</li>\n<li><strong>Clinical Features:</strong>\n<ul>\n<li>Marked fear and avoidance of blood, injury, or invasive medical procedures.</li>\n<li>Syncope or near-syncope due to <strong>vasovagal response</strong>.</li>\n<li>Can interfere with necessary healthcare (e.g., blood tests, vaccinations).</li>\n</ul>\n</li>\n<li><strong>Investigations:</strong>\n<ul>\n<li>Clinical diagnosis based on <strong>history and mental status examination</strong>.</li>\n<li>No laboratory tests needed.</li>\n</ul>\n</li>\n<li><strong>Management:</strong>\n<ul>\n<li><strong>CBT and exposure-based therapies</strong> (systematic desensitisation, gradual exposure).</li>\n<li><strong>Applied tension technique</strong>: Patients tense large muscle groups to prevent fainting during exposure.</li>\n<li>SSRIs or benzodiazepines in <strong>severe cases</strong></li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood-injection-injury</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Animal</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Natural environment</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Social situations</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">DSM-5 includes all of these types of specific phobia based on the phobic stimulus, except:</span></p>",
      "unique_key": "DT1154621",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154621,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>DSM-5 <strong>does not include social situations</strong> as a type of specific phobia. Social situations are classified separately under <strong>Social Anxiety Disorder (Social Phobia)</strong>.</p>\n<ul>\n<li><strong>Definition:</strong>\n<ul>\n<li><strong>Specific Phobia:</strong> Marked fear or anxiety about a specific object or situation.</li>\n<li><strong>Social Phobia (Social Anxiety Disorder):</strong> Intense fear of social or performance situations due to fear of embarrassment or scrutiny.</li>\n</ul>\n</li>\n<li><strong>Table: DSM-5 Classification of Specific Phobia</strong></li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715K8L.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Blood-injection-injury (Option A): </strong>This is a well-recognised DSM-5 specific phobia subtype. It involves intense fear of blood, injury, or medical procedures, and can cause a unique vasovagal response with bradycardia and fainting.</p>\n<p><strong>Animal (Option B): </strong>Animal type is one of the most common specific phobia categories. It includes fears of spiders, dogs, and snakes, and is typically seen in childhood-onset phobias.</p>\n<p><strong>Natural environment (Option C):</strong> This type includes fears of natural phenomena like storms and water. Often starts in childhood, reflecting a natural evolutionary sensitivity to environmental threats.</p>",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Meeting and having a conversation with unfamiliar people</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Being observed eating/drinking by people</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Giving a speech</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Social anxiety disorder refers to marked fear or anxiety due to possible scrutiny by others in which of the following situations?</span></p>",
      "unique_key": "DT1154622",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154622,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Social anxiety disorder is defined by a marked fear or anxiety in social situations where there is possible scrutiny by others, including all the scenarios mentioned.</p>\n<ul>\n<li><strong>Definition:</strong>\n<ul>\n<li>A persistent, intense fear of <strong>social or performance situations</strong> where embarrassment or negative evaluation may occur.</li>\n</ul>\n</li>\n<li><strong>Etiology:</strong>\n<ul>\n<li>Interaction of <strong>genetic predisposition</strong> and <strong>environmental factors</strong> (e.g., early social rejection, shyness).</li>\n</ul>\n</li>\n<li><strong>Pathophysiology:</strong>\n<ul>\n<li>Involves hyperactivity of the <strong>amygdala</strong> and increased <strong>autonomic nervous system responses</strong> to social stress.</li>\n</ul>\n</li>\n<li><strong>Clinical Features:</strong>\n<ul>\n<li>Fear in <strong>social interactions</strong> (meeting new people) <strong>(Option A)</strong>, <strong>being observed</strong> (e.g., eating, drinking) <strong>(Option B)</strong>, and <strong>performing</strong> (public speaking) <strong>(Option C)</strong>.</li>\n<li>Physical symptoms: <strong>blushing, sweating, trembling</strong>.</li>\n<li>Leads to <strong>avoidance</strong> or intense distress in these situations.</li>\n</ul>\n</li>\n<li><strong>Investigation:</strong>\n<ul>\n<li>Primarily <strong>clinical diagnosis</strong> using structured interviews (e.g., SCID).</li>\n<li>Scales like the <strong>Liebowitz Social Anxiety Scale (LSAS)</strong> are sometimes used.</li>\n</ul>\n</li>\n<li><strong>Management:</strong>\n<ul>\n<li><strong>CBT (cognitive behavioural therapy)</strong> with exposure therapy is first-line.</li>\n<li><strong>SSRIs</strong> (e.g., sertraline, paroxetine) and <strong>SNRIs</strong> can also be used.</li>\n<li><strong>Beta blockers</strong> (e.g., propranolol) are helpful for performance-type social anxiety.</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Use of beta-adrenergic receptor antagonists shortly before performing in important meetings</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Rehearsal for sessions and home-work assignments are helpful</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Both a and b</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Asking her to quit the job</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 29-year-old computer programmer was recently promoted to a managerial role, which involved frequent presentations and interactions with unfamiliar colleagues. She noticed that whenever she had to speak publicly, her heart would race, her mouth would become dry, and she would start sweating. She had persistent thoughts that others would ridicule her for \"saying stupid things,\" causing her to avoid important meetings altogether. What is the next best step in management?</span></p>",
      "unique_key": "DT1154624",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154624,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation :</strong></p>\n<p>This patient has <strong>social anxiety disorder (social phobia)</strong>, which can be managed using both short-term symptomatic treatment and cognitive-behavioural strategies.</p>\n<p><strong>Definition and Key Features:</strong></p>\n<ul>\n<li>Social anxiety disorder involves <strong>marked fear of social situations</strong> due to fear of scrutiny or embarrassment.</li>\n<li>Patients fear being negatively evaluated or humiliated in such settings.</li>\n</ul>\n<p><strong>Etiology:</strong></p>\n<ul>\n<li>It can result from genetic, environmental, and psychological factors.</li>\n<li>Common in young adults who are exposed to performance situations in professional roles.</li>\n</ul>\n<p><strong>Pathophysiology:</strong></p>\n<ul>\n<li>Heightened amygdala response to perceived social threats, with dysregulation of serotonin and norepinephrine pathways.</li>\n</ul>\n<p><strong>Clinical Features:</strong></p>\n<ul>\n<li>Palpitations, sweating, dry mouth, and muscle tension in social scenarios.</li>\n<li>Avoidance of social interactions or public speaking.</li>\n</ul>\n<p><strong>Investigations:</strong></p>\n<ul>\n<li>Diagnosis is clinical, based on DSM-5 criteria.</li>\n<li>Screening tools like the Liebowitz Social Anxiety Scale may be used.</li>\n</ul>\n<p><strong>Management:</strong></p>\n<p><strong>Short-term (Performance-specific situations):</strong></p>\n<ul>\n<li><strong>Beta-adrenergic antagonists</strong> (e.g., propranolol, atenolol) are used to control autonomic symptoms like palpitations and sweating. <strong>(Option A)</strong></li>\n</ul>\n<p><strong>Psychotherapy (Core management):</strong></p>\n<ul>\n<li>Cognitive retraining</li>\n<li>Desensitization</li>\n<li>Rehearsal of sessions <strong>(Option B)</strong></li>\n<li>Home-work assignments</li>\n</ul>\n<p><strong>Long-term pharmacotherapy (if needed):</strong></p>\n<ul>\n<li>SSRIs (e.g., sertraline, paroxetine)</li>\n<li>SNRIs (e.g., venlafaxine)</li>\n<li>Buspirone</li>\n<li>Benzodiazepines for short-term relief in severe cases<br /> </li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Asking her to quit the job (Option D)</strong>: Avoidance of job responsibilities is not recommended; treatment aims to restore confidence and performance.</p>\n<p><strong>Key Takeaways:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715M9N.png\">",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Depression with anxious distress</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Illness anxiety disorder</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Panic disorder</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Generalised anxiety disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Pinto, a 50-year-old man, reports persistent worries about 'everything under the sun,' including whether he returned a book to the library and concerns about his wife, who is undergoing breast cancer treatment. He finds it difficult to control his worries, experiencing muscle tension, poor sleep, and difficulty concentrating. These worries have worsened since his wife's diagnosis. What is the most appropriate diagnosis?</span></p>",
      "unique_key": "DT1154626",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154626,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\r\n<p>Pinto&rsquo;s <strong>excessive worry about various events and inability to control it for over 6 months</strong>, along with muscle tension, poor sleep, and concentration issues, aligns with <strong>Generalised Anxiety Disorder (GAD)</strong>.</p>\r\n<p><strong>Definition &amp; Key Features:</strong></p>\r\n<ul>\r\n<li>GAD involves <strong>excessive anxiety and worry about multiple life domains</strong>, occurring most days for at least <strong>6 months</strong>.</li>\r\n<li>The worry is <strong>difficult to control</strong> and causes <strong>clinically significant distress or impairment</strong>.</li>\r\n<li><strong>Somatic symptoms</strong> include muscle tension, irritability, restlessness, fatigue, poor concentration, and sleep disturbance.</li>\r\n</ul>\r\n<p><strong>Aetiology &amp; Pathophysiology:</strong></p>\r\n<ul>\r\n<li>Multifactorial: genetic predisposition, dysregulation of neurotransmitters (serotonin, norepinephrine, GABA), and environmental stressors.</li>\r\n</ul>\r\n<p><strong>Clinical Features Summary :</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715P1Q.png\">\r\n<p><strong>Investigations &amp; Diagnosis:</strong></p>\r\n<ul>\r\n<li>Clinical diagnosis based on DSM-5 criteria.</li>\r\n<li>Screening with the <strong>GAD-7 scale</strong>.</li>\r\n</ul>\r\n<p><strong>Management:</strong></p>\r\n<ul>\r\n<li><strong>Pharmacotherapy</strong>: SSRIs (escitalopram, sertraline), SNRIs, buspirone.</li>\r\n<li><strong>Psychotherapy</strong>: CBT is the first-line psychological approach.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Depression with anxious distress(Option A):</strong> The primary issue here is not a depressive episode, but chronic worry across multiple domains (criteria for major depressive episode not met).</p>\r\n<p><strong>Illness anxiety disorder(Option B):</strong> Focuses on <strong>fear of having a serious illness</strong>. Pinto worries about many things, not just health (not meeting the central theme of illness anxiety).</p>\r\n<p><strong>Panic disorder(Option C):</strong> Involves sudden, intense panic attacks. Pinto's worry is continuous and not episodic panic.</p>",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Feeling keyed up</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Difficulty in concentration</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Muscle tension</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which somatic symptoms are required in DSM-5 to make a diagnosis of generalised anxiety disorder?</span></p>",
      "unique_key": "DT1154631",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154631,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The <strong>DSM-5 criteria</strong> for Generalised Anxiety Disorder (GAD) specify the presence of <strong>excessive anxiety and worry</strong> occurring more days than not for at least <strong>6 months</strong> about various events or activities.</p>\n<p>This anxiety and worry are accompanied by <strong>three (or more) of the following six somatic symptoms</strong>, present for more days than not:</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715R2S.png\">",
      "correct_choice_id": 134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Benzodiazepines</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">SSRIs</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Buspirone</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Modafinil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following drugs can be used to treat Generalised anxiety disorder except:</span></p>",
      "unique_key": "DT1154633",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154633,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Modafinil is primarily used to treat excessive daytime sleepiness in narcolepsy and other sleep disorders, not for anxiety disorders.</p>\n<p><strong>Generalised Anxiety Disorder (GAD) Treatment:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715T3U.png\">\n\n<ul>\n<li><strong>Psychotherapy:</strong>\n<ul>\n<li>Cognitive retraining</li>\n<li>Desensitisation</li>\n<li>Rehearsal of sessions</li>\n<li>Home-work assignments</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715V4W.png\">",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Nucleus accumbens</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Left prefrontal cortex</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Amygdala</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Pituitary gland</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an area of the brain that appears to be most closely related to anxiety based on functional imaging studies?</span></p>",
      "unique_key": "DT1154641",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154641,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Functional neuroimaging consistently implicates the amygdala as the central hub of anxiety responses. It plays a critical role in processing and interpreting emotional stimuli, especially fear and threat perception.<br /> </li>\n<li><strong>Key Details on Amygdala in Anxiety:</strong>\n<ul>\n<li><strong>Location:</strong> Almond-shaped group of nuclei in the medial temporal lobe, part of the limbic system.</li>\n<li><strong>Function:</strong> Central to emotional processing (fear, anxiety, aggression) and linking external stimuli to emotional responses.</li>\n<li><strong>Relevance:</strong> Overactivity or dysregulation of the amygdala is linked with heightened anxiety and phobias.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Nucleus accumbens (Option A):</strong> Primarily involved in reward, motivation, and addiction circuits, not directly in anxiety.</p>\n<p><strong>Left prefrontal cortex (Option B):</strong> More associated with mood regulation, executive functions, and depression-related cognitive control.</p>\n<p><strong>Pituitary gland (Option D):</strong> Major endocrine regulator; while it modulates stress hormones (e.g., ACTH), it's not the central fear-processing hub like the amygdala.</p>",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Cognitive Behavioural Therapy</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">TMS</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Haloperidol</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Clozapine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">There is well-accepted evidence that one of the following treatments is effective in social anxiety disorder.</span></p>",
      "unique_key": "DT1154642",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154642,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Cognitive Behavioural Therapy (CBT) is consistently supported by high-quality evidence for treating social anxiety disorder (also known as social phobia). It addresses maladaptive thought patterns and behavioural avoidance central to this condition.</p>\n<p><strong>CBT in Social Anxiety Disorder:</strong></p>\n<ul>\n<li>Involves structured sessions to help patients identify, challenge, and change unhelpful thoughts related to social situations.</li>\n<li>Incorporates exposure exercises to reduce avoidance and improve confidence in social interactions.</li>\n<li>Typically regarded as the <strong>first-line psychotherapeutic treatment</strong> for social anxiety disorder.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>TMS (Option B):</strong> Transcranial Magnetic Stimulation is mainly studied for depression; limited and inconclusive evidence in social anxiety disorder.</p>\n<p><strong>Haloperidol (Option C):</strong> An antipsychotic not indicated for social anxiety.</p>\n<p><strong>Clozapine (Option D):</strong> Reserved for treatment-resistant schizophrenia; no role in treating social anxiety.</p>",
      "correct_choice_id": 161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Anxiety disorder due to another medical condition</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Generalized anxiety disorder</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Somatic symptom disorder</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Substance/medication-induced anxiety disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old female medical student presents with worsening headaches, fatigue, insomnia, and excessive worry over the past year related to her future, relationship, and career. Her boyfriend reports that she overreacts to minor issues. Which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "DT1154643",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154643,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient&rsquo;s excessive worry about multiple life domains, persistent fatigue, insomnia, and muscle tension for at least six months align with <strong>Generalised Anxiety Disorder (GAD)</strong>.</p>\n<p><strong>Definition and Features of GAD:</strong></p>\n<ul>\n<li>GAD involves chronic and excessive anxiety and worry about various aspects of daily life, difficult to control, for at least <strong>six months</strong>.</li>\n<li>Somatic symptoms include restlessness, muscle tension, sleep disturbances, fatigue, and irritability.</li>\n</ul>\n<p><strong>Aetiology and Pathophysiology:</strong></p>\n<ul>\n<li>Thought to involve genetic predisposition, early environmental stressors, and dysregulation of serotonin, norepinephrine, and GABA neurotransmission.</li>\n</ul>\n<p><strong>Clinical Features:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715X5Y.png\">\n<p><strong>Investigations:</strong></p>\n<ul>\n<li>Primarily clinical diagnosis, but ruling out medical causes (thyroid dysfunction, anaemia) is essential when somatic symptoms are prominent.</li>\n</ul>\n<p><strong>Management:</strong></p>\n<ul>\n<li><strong>Psychotherapy:</strong> Cognitive-behavioural therapy (CBT) focuses on identifying and challenging maladaptive thought patterns.</li>\n<li><strong>Pharmacotherapy:</strong> SSRIs (e.g., escitalopram, sertraline), SNRIs (e.g., venlafaxine), and buspirone for long-term management. Benzodiazepines are used only for short-term severe symptoms.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Anxiety disorder due to another medical condition (Option A):</strong> No evidence of an underlying medical condition driving the anxiety in this case.</p>\n<p><strong>Somatic symptom disorder (Option C):</strong> Patient is not preoccupied with or excessively anxious about her physical symptoms (e.g., headaches); instead, she worries about life stressors.</p>\n<p><strong>Substance/medication-induced anxiety disorder (Option D):</strong> No mention of substance use or medications causing or exacerbating the anxiety.</p>",
      "correct_choice_id": 172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">CBT</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">CBT and Escitalopram</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Psychoeducation and Lorazepam</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Psychodynamic Psychotherapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 37-year-old male professor with a history of GAD and MDD presents with worsening anxiety and self-doubt after poor student reviews. He is hesitant to use medications that may affect his cognition. What is the most effective treatment approach?</span></p>",
      "unique_key": "DT1154644",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154644,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The best approach is a <strong>combination of cognitive-behavioural therapy (CBT) and an SSRI</strong> such as escitalopram, which is specifically FDA-approved for Generalised Anxiety Disorder (GAD). This combination addresses both the psychological and biological aspects of his anxiety and depressive symptoms.</p>\n<p><strong>Definition and Key Features:</strong></p>\n<ul>\n<li><strong>Generalised Anxiety Disorder (GAD):</strong> Characterised by persistent and excessive worry about multiple life circumstances for at least 6 months, often associated with somatic symptoms like muscle tension, restlessness, and insomnia.</li>\n<li><strong>Major Depressive Disorder (MDD):</strong> Characterised by low mood, anhedonia, fatigue, feelings of worthlessness, and cognitive difficulties, often coexisting with anxiety in such patients.</li>\n</ul>\n<p><strong>Aetiology and Pathophysiology:</strong></p>\n<ul>\n<li>Involves <strong>genetic vulnerability, stressful life events</strong>, and <strong>neurotransmitter dysregulation</strong> (serotonin, norepinephrine, GABA).</li>\n</ul>\n<p><strong>Clinical Features:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715Z6A.png\">\n<p><strong>Management:</strong></p>\n<ul>\n<li><strong>CBT:</strong> Focuses on modifying maladaptive thoughts and reducing behavioural avoidance.</li>\n<li><strong>SSRIs (Escitalopram):</strong> Shown to be effective for both GAD and MDD, with minimal impact on cognitive performance compared to benzodiazepines.</li>\n<li>Combined treatment is particularly recommended for <strong>moderate to severe functional impairment</strong>, as seen in this professor.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>CBT(Option A):</strong> Beneficial but less effective alone in severe or comorbid cases with MDD.</p>\n<p><strong>Psychoeducation and Lorazepam(Option C):</strong> Lorazepam is not suitable for long-term use, can worsen depression, and cause cognitive impairment- concerns that match the patient&rsquo;s hesitancy.</p>\n<p><strong>Psychodynamic Psychotherapy(Option D):</strong> While helpful for some, CBT with medication has stronger evidence in anxiety disorders.</p>",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Agoraphobia</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Generalized Anxiety Disorder</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Panic Disorder</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Social Anxiety disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old businessman describes a persistent fear of speaking in public. While he is comfortable in one-on-one situations, giving a lecture to a group causes him to feel extreme anxiety and worry about being humiliated. He recalls one episode when he was forced to speak unexpectedly and experienced intense panic with shaking, abdominal cramps, and a fear that he would lose bowel control. This fear has limited his career progression, as he avoids all public speaking opportunities. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1154645",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154645,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient's fear is specifically related to social or performance situations - <strong>public speaking</strong> - where he worries about being humiliated or negatively evaluated, consistent with <strong>Social Anxiety Disorder (Social Phobia)</strong>.</p>\n<p><strong>Definition and Key Features:</strong></p>\n<ul>\n<li>Social Anxiety Disorder involves intense, persistent fear of social or performance situations in which one may be scrutinised by others.</li>\n<li>The individual fears that they will act in a way or show anxiety symptoms that will be humiliating.</li>\n</ul>\n<p><strong>Aetiology and Pathophysiology:</strong></p>\n<ul>\n<li>Involves genetic predisposition and environmental factors (e.g., negative social experiences).</li>\n<li>Dysregulation of <strong>amygdala-centred circuits</strong> that process social threat.</li>\n</ul>\n<p><strong>Clinical Features:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715A7C.png\">\n<p><strong>Investigations:</strong></p>\n<ul>\n<li>Primarily a <strong>clinical diagnosis</strong> based on history and DSM-5 criteria.</li>\n</ul>\n<p><strong>Management:</strong></p>\n<ul>\n<li><strong>Cognitive Behavioural Therapy (CBT):</strong> Structured exposure and cognitive restructuring.</li>\n<li><strong>Pharmacotherapy:</strong> SSRIs (e.g., sertraline, paroxetine) and SNRIs; beta-blockers (e.g., propranolol) may help with performance-specific anxiety.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Agoraphobia(Option A):</strong> Involves fear of places/situations from which escape might be difficult (e.g., crowded places, open spaces), not specific performance fears.</p>\n<p><strong>Generalised Anxiety Disorder(Option B):</strong> Involves excessive worry across many life domains, not just public speaking.</p>\n<p><strong>Panic Disorder(Option C):</strong> Characterised by recurrent, unexpected panic attacks and worry about having more attacks, not consistently triggered by specific social situations.</p>",
      "correct_choice_id": 194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Agoraphobia</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Generalized Anxiety Disorder</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Panic Disorder</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Specific phobia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old woman avoids leaving her home due to fear of \"freaking out\" and not being able to get help. When travelling alone, she experiences episodes of intense fear with chest pain, sweating, and dizziness. She now avoids going out without company and depends on others for daily tasks. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1154647",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154647,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The patient&rsquo;s symptoms of <strong>persistent fear of being in situations where escape may be difficult or help unavailable if a panic attack occurs</strong> align with <strong>agoraphobia</strong>.</p>\r\n<p><strong>Definition and Key Features:</strong></p>\r\n<ul>\r\n<li><strong>Agoraphobia:</strong> Fear or anxiety about situations (e.g., using public transportation, being in open spaces, being in a crowd) due to concern that <strong>escape might be difficult</strong> or help unavailable in the event of panic-like symptoms or other incapacitating symptoms.</li>\r\n<li>Such fear leads to <strong>active avoidance</strong> of these situations, requiring accompaniment by trusted individuals or enduring them with marked distress.</li>\r\n</ul>\r\n<p><strong>Aetiology and Pathophysiology:</strong></p>\r\n<ul>\r\n<li>Often develops after initial panic attacks in these settings, leading to <strong>conditioning</strong> of fear to those environments.</li>\r\n<li>Involves dysfunction of the <strong>amygdala and related circuits</strong> responsible for processing fear and threat perception.</li>\r\n</ul>\r\n<p><strong>Clinical Features:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715B8D.png\">\r\n<p><strong>Investigations and Diagnosis:</strong></p>\r\n<ul>\r\n<li>Clinical diagnosis based on DSM-5 criteria and thorough history.</li>\r\n<li>Rule out medical causes for panic-like symptoms.</li>\r\n</ul>\r\n<p><strong>Management:</strong></p>\r\n<ul>\r\n<li><strong>CBT with exposure-based therapy</strong> to reduce avoidance behaviours.</li>\r\n<li><strong>SSRIs and SNRIs</strong> as first-line pharmacotherapy for persistent agoraphobia symptoms.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Generalised Anxiety Disorder (Option B):</strong> Incorrect because it involves excessive worry across various domains, not specifically linked to fear of public or crowded places. GAD features persistent worry about finances, health, and minor matters, with associated somatic symptoms like restlessness and fatigue.</p>\r\n<p><strong>Panic Disorder (Option C):</strong> Incorrect because panic attacks in panic disorder are unexpected, not consistently tied to specific triggers like in this patient&rsquo;s case. Panic disorder is marked by recurrent, unprovoked panic attacks and ongoing concern about future attacks.</p>\r\n<p><strong>Specific Phobia (Option D):</strong> Incorrect because the fear here is related to being in public spaces where escape might be difficult, not a single, specific object or animal. Specific phobia involves excessive fear of distinct objects or situations (e.g., flying, animals).</p>",
      "correct_choice_id": 201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Agoraphobia</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Generalized Anxiety Disorder</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Panic Disorder</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Specific phobia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old single woman reports that she has always been afraid of heights. She becomes very anxious when in high places (e.g., higher than three stories) and even worries about the height of buildings when travelling or shopping. When exposed to heights, she experiences severe anxiety symptoms, including trembling, dizziness, tingling sensations, and a fear of dying. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1154648",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154648,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>This patient has a <strong>marked fear of a specific situation (heights)</strong> that consistently provokes anxiety, fitting the criteria for <strong>specific phobia</strong>.</p>\n<p><strong>Definition and Key Features:</strong></p>\n<ul>\n<li>Specific phobia involves a <strong>marked and persistent fear</strong> that is excessive or unreasonable, triggered by the presence or anticipation of a <strong>specific object or situation</strong> (e.g., heights, animals, flying).</li>\n<li>Exposure to the phobic stimulus almost always provokes an <strong>immediate anxiety response</strong> (e.g., sweating, palpitations, dizziness).</li>\n<li>The person recognises the fear as excessive but still avoids the situation or endures it with intense distress.</li>\n</ul>\n<p><strong>Aetiology and Pathophysiology:</strong></p>\n<ul>\n<li>Often develops in childhood through <strong>traumatic experiences</strong> or modelling (observing others with similar fears).</li>\n<li>Involves hyperactivity in the <strong>amygdala-centred fear circuits</strong> and learned associations.</li>\n</ul>\n<p><strong>Clinical Features:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715C9E.png\">\n<p><strong>Investigations and Diagnosis:</strong></p>\n<ul>\n<li>Diagnosis is <strong>clinical</strong> using DSM-5 criteria, based on history and symptom pattern.</li>\n</ul>\n<p><strong>Management:</strong></p>\n<ul>\n<li><strong>CBT with exposure therapy</strong>: Gradual exposure to heights to reduce anxiety response.</li>\n<li><strong>Pharmacotherapy:</strong> Limited role; short-term benzodiazepines may be used in severe anticipatory anxiety but are not first-line treatment.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Agoraphobia (Option A):</strong> Agoraphobia involves fear of being in places where escape might be difficult or help unavailable, not a specific fear of heights. It typically includes fear of crowded places, using public transportation, or being alone outside the home.</p>\n<p><strong>Generalised Anxiety Disorder (Option B):</strong> GAD involves persistent worry across multiple domains, not situational fear of heights. GAD patients experience chronic worry about a range of everyday issues, not specific phobic triggers.</p>\n<p><strong>Panic Disorder (Option C):</strong> In panic disorder, panic attacks are <strong>unexpected and recurrent</strong>, not triggered consistently by specific situations like heights. Panic disorder patients also develop persistent concern about future attacks and behavioural changes to avoid them.</p>",
      "correct_choice_id": 214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Agoraphobia</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Generalized Anxiety Disorder</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Panic Disorder</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Social Anxiety disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 33-year-old man has recurrent episodes of intense fear with palpitations, sweating, breathlessness, and numbness. Despite a normal cardiac workup, he fears a heart attack like his father's. His daily routine remains largely unaffected. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1154649",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154649,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The patient's <strong>recurrent, sudden-onset episodes of intense fear accompanied by physical symptoms</strong> (palpitations, shortness of breath, sweating) strongly suggest <strong>panic disorder</strong>.</p>\r\n<p><strong>Definition and Key Features:</strong></p>\r\n<ul>\r\n<li><strong>Panic disorder</strong> involves recurrent, <strong>unexpected panic attacks</strong>&mdash;sudden episodes of intense fear or discomfort peaking within minutes.</li>\r\n<li>Physical symptoms include palpitations, sweating, trembling, chest pain, dizziness, and fear of dying or losing control.</li>\r\n<li>Patients develop <strong>persistent concern</strong> about future attacks and their consequences.</li>\r\n</ul>\r\n<p><strong>Aetiology and Pathophysiology:</strong></p>\r\n<ul>\r\n<li>Thought to involve <strong>hypersensitivity of the locus coeruleus</strong> and dysregulation of noradrenergic and serotonergic systems.</li>\r\n<li>Genetic predisposition and environmental triggers (like early trauma or loss) contribute.</li>\r\n</ul>\r\n<p><strong>Clinical Features:</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715D1F.png\">\r\n<p><strong>Investigations and Diagnosis:</strong></p>\r\n<ul>\r\n<li>Primarily <strong>clinical diagnosis</strong> based on history.</li>\r\n<li>Rule out medical conditions (e.g., cardiac arrhythmias, thyroid dysfunction).</li>\r\n</ul>\r\n<p><strong>Management:</strong></p>\r\n<ul>\r\n<li><strong>CBT:</strong> Focuses on identifying triggers, cognitive restructuring, and gradual exposure.</li>\r\n<li><strong>Pharmacotherapy:</strong> SSRIs (first-line) and benzodiazepines (short-term relief in severe attacks).</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Agoraphobia (Option A):</strong> Agoraphobia involves fear of situations where escape might be difficult (e.g., crowds, public transportation), which is not described here. Agoraphobia often develops as a consequence of panic disorder if patients begin to avoid such situations to prevent attacks.</p>\r\n<p><strong>Generalised Anxiety Disorder (Option B):</strong> GAD involves <strong>persistent worry about various aspects of daily life</strong>, not sudden, intense episodes. GAD typically includes restlessness, muscle tension, and ongoing worry rather than episodic attacks.</p>\r\n<p><strong>Social Anxiety Disorder (Option D):</strong> Social phobia is about fear of embarrassment in social settings, not sudden panic episodes. Patients with social anxiety disorder avoid performance situations or social interactions.</p>",
      "correct_choice_id": 223,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Place on home-bound tutoring to be provided by the school district</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Prescribe lorazepam pro re nata for anxiety episodes</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Start fluoxetine in a low dose</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Reassure the mother that it's just a phase and will pass on its own</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old boy has repeated episodes of somatic complaints (like stomachaches), anxiety, and crying at school, which resolve when he is sent home. He refuses to go anywhere without his mother and becomes extremely distressed if separated from her. What is an appropriate part of the plan for his treatment?</span></p>",
      "unique_key": "DT1154651",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154651,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This child's symptoms are characteristic of <strong>separation anxiety disorder </strong>- an excessive and developmentally inappropriate fear of separation from attachment figures, typically seen in childhood.</p>\r\n<p><strong>Definition and Key Features:</strong></p>\r\n<ul>\r\n<li>Marked distress when separated from home or major attachment figures.</li>\r\n<li>Physical symptoms (e.g., headaches, stomachaches) that resolve when back with the attachment figure.</li>\r\n<li>Refusal to attend school or other activities that involve separation.</li>\r\n</ul>\r\n<p><strong>Etiology:</strong></p>\r\n<ul>\r\n<li>Influenced by genetic predisposition and family dynamics (overprotection, parental anxiety).</li>\r\n</ul>\r\n<p><strong>Pathophysiology:</strong></p>\r\n<ul>\r\n<li>Involves heightened reactivity of the amygdala-centred circuits associated with fear and separation.</li>\r\n</ul>\r\n<p><strong>Clinical Features:</strong></p>\r\n<ul>\r\n<li>Fear of harm befalling attachment figures.</li>\r\n<li>Clinging behaviour and refusal to be alone or leave home.</li>\r\n<li>Somatic complaints during separation situations.</li>\r\n</ul>\r\n<p><strong>Investigation and Diagnosis:</strong></p>\r\n<ul>\r\n<li>Clinical diagnosis based on DSM-5 criteria.</li>\r\n<li>Rule out medical conditions for somatic symptoms.</li>\r\n</ul>\r\n<p><strong>Management:</strong></p>\r\n<ul>\r\n<li><strong>Psychotherapy:</strong> Behavioural and family-based therapies to gradually increase separation tolerance.</li>\r\n<li><strong>Pharmacotherapy:</strong> SSRIs like fluoxetine are used when symptoms cause significant functional impairment or are resistant to behavioural therapy.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Home-bound tutoring (Option A):</strong> Incorrect because it reinforces the child&rsquo;s avoidance of separation and limits social development. Avoiding school perpetuates anxiety and prevents learning coping skills.</p>\r\n<p><strong>Lorazepam (Option B):</strong> Incorrect because benzodiazepines have potential for dependence, sedation, and disinhibition in children, making them unsuitable for pediatric separation anxiety. They are generally avoided in children except in extreme, short-term crisis situations.</p>\r\n<p><strong>Reassurance to mother (Option D):</strong> Incorrect because separation anxiety disorder can persist and increase the risk of future anxiety and depressive disorders. Early treatment helps reduce the long-term impact.</p>",
      "correct_choice_id": 233,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Somatization disorder</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Bipolar disorder</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Learning Disability</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Major Depression</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Children or adolescents with separation anxiety disorder are at higher risk for which other psychiatric disorder?</span></p>",
      "unique_key": "DT1154654",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154654,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Separation anxiety disorder is linked to an increased risk of developing <strong>major depression</strong> later in life, likely due to persistent stress and maladaptive coping mechanisms established early.</p>\n<p><strong>Key Features of the Link to Major Depression:</strong></p>\n<ul>\n<li>Chronic anxiety in childhood can lead to <strong>hopelessness and feelings of helplessness</strong>, increasing vulnerability to depression.</li>\n<li>Adolescents may withdraw from social and academic activities, reinforcing negative mood states.</li>\n<li>Family history of anxiety and mood disorders also plays a role in this progression.</li>\n</ul>\n<p><strong>Etiological Considerations:</strong></p>\n<ul>\n<li>Shared genetic factors and environmental influences (e.g., parental overprotection, family stress) contribute to the comorbidity.</li>\n<li>Early-life stress responses shape later mood regulation and resilience.</li>\n</ul>\n<p><strong>Investigation and Diagnosis:</strong></p>\n<ul>\n<li>Comprehensive psychiatric evaluation focusing on <strong>mood symptoms</strong>, social functioning, and academic history.</li>\n</ul>\n<p><strong>Management:</strong></p>\n<ul>\n<li>Early intervention for separation anxiety (behavioural strategies, family work) can reduce the risk of progression.</li>\n<li>If depressive symptoms develop, combined <strong>psychotherapy</strong> and <strong>antidepressant medications</strong> are indicated.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Somatisation disorder (Option A):</strong> Incorrect because although children with separation anxiety may have somatic complaints, these do not typically progress to a somatisation disorder in adulthood. Somatisation disorder involves multiple unexplained physical symptoms across different organ systems, beginning before age 30.</p>\n<p><strong>Bipolar disorder (Option B):</strong> Incorrect because separation anxiety disorder does not significantly increase the risk of bipolar disorder. Bipolar disorder involves episodes of mania and depression, distinct from the anxiety seen in separation anxiety.</p>\n<p><strong>Learning disability (Option C):</strong> Incorrect because separation anxiety disorder is not linked to cognitive or learning disabilities. Learning disabilities involve specific difficulties in reading, writing, or math unrelated to anxiety disorders.</p>",
      "correct_choice_id": 244,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypovolemia</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertension</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Anorexia</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Suicidal thoughts</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">When starting an SSRI, such as fluoxetine, in an adolescent patient with separation anxiety disorder, the Food and Drug Administration(FDA) recommends the clinician monitor closely for which of the following?</span></p>",
      "unique_key": "DT1154655",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154655,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Starting an SSRI in adolescents has been associated with a <strong>small but significant increase in suicidal thoughts and behaviours</strong>, warranting close monitoring.</p>\n<p><strong>Key Considerations:</strong></p>\n<ul>\n<li>The FDA recently placed a black box warning for the use of antidepressants in children and adolescents. This FDA black box warning applies to all antidepressants in children and adolescents, including SSRIs.</li>\n<li>Early follow-up is critical to assess for any emergence of suicidal ideation or behavioural changes.</li>\n</ul>\n<p><strong>Aetiology and Pathophysiology of Risk:</strong></p>\n<ul>\n<li>It is thought to be linked to early improvement in energy before mood improves, which can transiently increase the risk of acting on suicidal thoughts.</li>\n</ul>\n<p><strong>Investigation and Monitoring:</strong></p>\n<ul>\n<li>Frequent check-ins with the patient and family, especially in the first weeks of treatment.</li>\n</ul>\n<p><strong>Management:</strong></p>\n<ul>\n<li>Ongoing psychotherapy and family support alongside pharmacotherapy.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Hypovolemia (Option A):</strong> Not a known side effect of SSRIs. Hypovolemia typically results from fluid losses or dehydration, not from antidepressant use.</p>\n<p><strong>Hypertension (Option B):</strong> SSRIs do not cause high blood pressure. Hypertension is more commonly linked to other classes of medications, not typically SSRIs.</p>\n<p><strong>Anorexia (Option C):</strong> Decreased appetite may occur, but it is not the primary safety concern. Appetite changes with SSRIs are usually mild and transient, not life-threatening.</p>",
      "correct_choice_id": 254,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Venlafaxine</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Benzodiazepines</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Tricyclic antidepressants</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">SSRI</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In controlled studies, which of the following medications is less effective for use in childhood anxiety disorders?</span></p>",
      "unique_key": "DT1154656",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154656,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Benzodiazepines have not demonstrated efficacy</strong> in controlled trials for treating childhood anxiety disorders. They may worsen behaviour (disinhibition) and cause sedation, making them generally avoided in children.</p>\n<p><strong>Evidence from Controlled Studies:</strong></p>\n<ul>\n<li><strong>SSRIs:</strong> Have consistently demonstrated efficacy in treating childhood anxiety disorders (e.g., separation anxiety, social phobia, generalised anxiety disorder).</li>\n<li><strong>Venlafaxine:</strong> An SNRI that has shown some evidence of effectiveness in childhood anxiety but is used cautiously due to potential side effects.</li>\n<li><strong>Tricyclic Antidepressants:</strong> Have modest evidence of benefit, but are considered second-line due to their side effect profile.</li>\n</ul>\n<p><strong>Investigation and Monitoring:</strong></p>\n<ul>\n<li><strong>Clinical evaluation</strong> to determine the severity of anxiety and assess for comorbidities before starting pharmacotherapy.</li>\n<li><strong>Ongoing monitoring</strong> for medication response and side effects.</li>\n</ul>\n<p><strong>Management:</strong></p>\n<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250724a4e79422-cbfa-4872-9918-7bc8a280a5a3.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Venlafaxine (Option A):</strong> While used cautiously, some controlled studies support its use in childhood anxiety disorders. Venlafaxine may be considered when SSRIs are ineffective, though it has more cardiovascular side effects.</p>\n<p><strong>Tricyclic Antidepressants (Option C):</strong> Trials have shown some benefit, but they are used less due to safety concerns. They may be considered second-line when SSRIs are ineffective or poorly tolerated.</p>\n<p><strong>SSRIs (Option D):</strong> SSRIs are the first-line pharmacotherapy for childhood anxiety disorders, with robust evidence of effectiveness. SSRIs are well-tolerated in children when monitored carefully.</p>",
      "correct_choice_id": 262,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Anxiety disorder due to another medical condition</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Generalized anxiety disorder</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Substance/medication-induced anxiety disorder</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Specific phobia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old male with hypothyroidism reports recent anxiety, jitteriness, palpitations, and poor sleep. These symptoms began after he started consuming an herbal tea daily that claims to boost intelligence. His thyroid status is stable. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1154657",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154657,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient's symptoms are <strong>temporally linked to the consumption of an herbal tea</strong> likely containing stimulants like caffeine, leading to the diagnosis of <strong>substance/medication-induced anxiety disorder</strong>.</p>\n<p><strong>Definition:</strong></p>\n<p>Substance/medication-induced anxiety disorder is characterised by <strong>prominent anxiety symptoms</strong> directly caused by exposure to a drug or stimulant, not explained by another primary anxiety disorder.</p>\n<p><strong>Aetiology and Pathophysiology:</strong></p>\n<ul>\n<li>Caffeine and other herbal stimulants increase <strong>sympathetic nervous system activity</strong>, causing autonomic hyperactivity.</li>\n<li>High doses can trigger <strong>palpitations, tremulousness, and sleep disruption</strong>.</li>\n<li>Repeated use can heighten physiological arousal and precipitate anxiety.</li>\n</ul>\n<p><strong>Clinical Features:</strong></p>\n<ul>\n<li>Sudden onset of intense anxiety, jitteriness, and restlessness following consumption of the stimulant-containing tea.</li>\n<li>Palpitations, difficulty sleeping, and heightened autonomic arousal.</li>\n<li>No evidence of persistent worry across multiple life areas, differentiating it from generalised anxiety disorder.</li>\n<li>Symptoms usually resolve once the stimulant is discontinued.</li>\n</ul>\n<p><strong>Investigation and Diagnosis:</strong></p>\n<ul>\n<li>Careful history-taking to identify substance-related triggers.</li>\n<li>Exclude medical conditions (thyroid dysfunction) that can also cause anxiety symptoms.</li>\n<li>Diagnosis is clinically based on temporal association with substance use.</li>\n</ul>\n<p><strong>Management:</strong></p>\n<ul>\n<li>Advise the patient to reduce or discontinue the herbal tea.</li>\n<li>Supportive care for mild withdrawal symptoms if present.</li>\n<li>Monitor for resolution of symptoms; if persistent, consider an underlying anxiety disorder.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Anxiety disorder due to another medical condition (Option A):</strong> Incorrect because his thyroid disease is well-controlled, and no other medical condition is identified as causing the anxiety. This diagnosis requires a clear direct link to a medical condition (e.g., untreated hyperthyroidism).</p>\n<p><strong>Generalised Anxiety Disorder (Option B):</strong> Incorrect because GAD involves excessive worry about a range of life areas for at least six months, not linked to an external substance. GAD features include muscle tension, fatigue, and irritability due to chronic worry.</p>\n<p><strong>Specific Phobia (Option D):</strong> Incorrect because no specific object or situation is causing the fear. Specific phobia involves disproportionate fear of clearly defined situations (e.g., animals, heights).</p>",
      "correct_choice_id": 273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4, 5</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 5</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4, 5</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4, 5, 6</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Of the following six substances, which are known to be capable of causing anxiety disorders (either during intoxication or withdrawal)?<br> 1. Alcohol<br> 2. Caffeine<br> 3. Cannabis<br> 4. Opioids<br> 5. Cocaine<br> 6. Antipsychotics</span></p>",
      "unique_key": "DT1154658",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154658,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Substances such as <strong>alcohol, caffeine, cannabis, opioids, and cocaine</strong> have been associated with the induction or exacerbation of anxiety symptoms:</p>\n<ul>\n<li><strong>Alcohol:</strong> Anxiety can develop during withdrawal and chronic misuse.</li>\n<li><strong>Caffeine:</strong> Directly increases sympathetic activity, causing jitteriness and anxiety.</li>\n<li><strong>Cannabis:</strong> Can trigger paranoia and panic reactions in some users.</li>\n<li><strong>Opioids:</strong> Anxiety can emerge during withdrawal states.</li>\n<li><strong>Cocaine:</strong> Potent stimulant, causes intense anxiety, restlessness, and paranoia.</li>\n</ul>\n<p><strong>Antipsychotics </strong>are not typically associated with inducing anxiety disorders. They are used in treating psychotic and mood disorders, not in causing primary anxiety syndromes</p>",
      "correct_choice_id": 281,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30,
      "choices": [
        {
          "id": 291,
          "text": "<p><span style=\"font-size:12.0pt;\">In elevators or shopping malls</span></p>"
        },
        {
          "id": 292,
          "text": "<p><span style=\"font-size:12.0pt;\">Using public transport like bus</span></p>"
        },
        {
          "id": 293,
          "text": "<p><span style=\"font-size:12.0pt;\">Standing in a queue</span></p>"
        },
        {
          "id": 294,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">According to DSM-5, marked fear or anxiety in which of the following situations may be seen in Agoraphobia?</span></p>",
      "unique_key": "DT1154865",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154865,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong><br /> The DSM-5 diagnostic criteria for <strong>agoraphobia</strong> include marked fear or anxiety about <strong>two or more of five specific situations</strong>:</p>\n<ul>\n<li>Using public transportation <strong>(Option B)</strong></li>\n<li>Being in open spaces</li>\n<li>Being in enclosed spaces <strong>(Option A)</strong></li>\n<li>Standing in line or being in a crowd <strong>(Option C)</strong></li>\n<li>Being outside of home alone</li>\n</ul>\n<p>These fears are rooted in concerns about being unable to escape or access help in the event of panic-like or other incapacitating symptoms.</p>\n<p><strong>Definition and Key Features:</strong></p>\n<ul>\n<li>Agoraphobia involves anxiety about places or situations where escape might be difficult or help unavailable.</li>\n<li>The anxiety leads to avoidance, enduring situations with great distress, or needing a companion to enter them.</li>\n</ul>\n<p><strong>Aetiology and Pathophysiology:</strong></p>\n<ul>\n<li>Commonly follows panic attacks, conditioning fear to settings where attacks occurred.</li>\n<li>Neural circuits involved include the amygdala and its connections to the prefrontal cortex and hippocampus.</li>\n</ul>\n<p><strong>Clinical Features:</strong></p>\n<ul>\n<li>Avoidance or extreme distress in any of these five situations.</li>\n<li>Dependence on trusted companions for daily tasks due to fear of public places.</li>\n<li>Symptoms persist for at least six months.</li>\n</ul>\n<p><strong>Investigations and Diagnosis:</strong></p>\n<ul>\n<li>Clinical diagnosis based on history and exclusion of other medical or psychiatric conditions.</li>\n</ul>\n<p><strong>Management:</strong></p>\n<ul>\n<li>First-line treatment: <strong>CBT with exposure-based therapy</strong> to reduce avoidance behaviour.</li>\n<li><strong>SSRIs or SNRIs</strong> as pharmacotherapy for persistent symptoms.</li>\n</ul>",
      "correct_choice_id": 294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31,
      "choices": [
        {
          "id": 301,
          "text": "<p><span style=\"font-size:12.0pt;\">Koro syndrome</span></p>"
        },
        {
          "id": 302,
          "text": "<p><span style=\"font-size:12.0pt;\">Dhat syndrome</span></p>"
        },
        {
          "id": 303,
          "text": "<p><span style=\"font-size:12.0pt;\">Ataque de nervcios</span></p>"
        },
        {
          "id": 304,
          "text": "<p><span style=\"font-size:12.0pt;\">Shamanism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following culture-bound syndromes gives anxiety to a young boy, where he has the belief that he is losing his virility because he experiences a loss of blood along with semen?</span></p>",
      "unique_key": "DT1154866",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154866,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient's belief of losing strength and virility due to the perceived loss of semen mixed with blood aligns with <strong>Dhat syndrome</strong>.</p>\n<p><strong>Definition and Key Features:</strong></p>\n<ul>\n<li><strong>Dhat syndrome</strong> is a culture-bound syndrome common in the Indian subcontinent, involving <strong>anxiety and somatic complaints</strong> associated with the belief that semen loss leads to physical and mental weakness.</li>\n<li>Patients often attribute nonspecific symptoms like fatigue, weakness, and anxiety to semen loss in urine or during nocturnal emissions.</li>\n</ul>\n<p><strong>Aetiology and Pathophysiology:</strong></p>\n<ul>\n<li>Sociocultural beliefs regarding the vital nature of semen and its conservation in traditional systems of medicine contribute to this syndrome.</li>\n<li>The condition is driven by misinterpretation of normal physiological processes and heightened anxiety.</li>\n</ul>\n<p><strong>Clinical Features:</strong></p>\n<ul>\n<li>Somatic complaints: fatigue, weakness, palpitations.</li>\n<li>Psychological symptoms: depressive features, anxiety, guilt over perceived semen loss.</li>\n<li>Often occurs in the context of sexual guilt or misinformation about sexual health.</li>\n</ul>\n<p><strong>Investigations and Diagnosis:</strong></p>\n<ul>\n<li>Diagnosis is clinical and based on the patient's culturally influenced beliefs and associated somatic symptoms.</li>\n<li>No specific laboratory tests are needed, but evaluation for underlying physical illness can be reassuring.</li>\n</ul>\n<p><strong>Management:</strong></p>\n<ul>\n<li><strong>Psychoeducation</strong> to correct misconceptions about semen physiology.</li>\n<li><strong>Cognitive Behavioural Therapy (CBT)</strong> to address maladaptive beliefs and reduce anxiety.</li>\n<li><strong>Antidepressants</strong> may be used if significant depressive or anxiety symptoms are present.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Koro syndrome (Option A):</strong> Incorrect because it involves the fear that the penis is retracting into the abdomen, not semen loss. Koro is marked by intense panic and fear of genital retraction with possible fatal consequences.</p>\n<p><strong>Ataque de nervios (Option C):</strong> Incorrect, as it is a Latin American syndrome involving sudden outbursts of intense emotional distress, usually in response to stressful family events. Features include crying, trembling, and feeling out of control.</p>\n<p><strong>Shamanism (Option D):</strong> Incorrect, as shamanism refers to traditional healing practices and spiritual rituals, not an anxiety-related syndrome linked to semen loss.</p>",
      "correct_choice_id": 302,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}